(2S)-1-[2-[(2-cyclohexa-1,5-dien-1-ylacetyl)amino]acetyl]-N-(3-fluoro-2-oxopropyl)pyrrolidine-2-carboxamide
C18H24FN3O4 — CID 155418284
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-1-[2-[(2-cyclohexa-1,5-dien-1-ylacetyl)amino]acetyl]-N-(3-fluoro-2-oxopropyl)pyrrolidine-2-carboxamide
(2S)-1-[2-[(2-cyclohexa-1,5-dien-1-ylacetyl)amino]acetyl]-N-(3-fluoro-2-oxopropyl)pyrrolidine-2-carboxamide (PubChem CID 155418284) has the molecular formula C18H24FN3O4 and a molecular weight of 365.41 g/mol. Its IUPAC name is (2S)-1-[2-[(2-cyclohexa-1,5-dien-1-ylacetyl)amino]acetyl]-N-(3-fluoro-2-oxopropyl)pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S)-1-[2-[(2-cyclohexa-1,5-dien-1-ylacetyl)amino]acetyl]-N-(3-fluoro-2-oxopropyl)pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 155418284 |
| Molecular Formula | C18H24FN3O4 |
| Molecular Weight | 365.41 g/mol |
| Exact Mass | 365.18 |
| IUPAC Name | (2S)-1-[2-[(2-cyclohexa-1,5-dien-1-ylacetyl)amino]acetyl]-N-(3-fluoro-2-oxopropyl)pyrrolidine-2-carboxamide |
| SMILES | O=C(CF)CNC(=O)[C@@H]1CCCN1C(=O)CNC(=O)CC1=CCCC=C1 |
| InChI | InChI=1S/C18H24FN3O4/c19-10-14(23)11-21-18(26)15-7-4-8-22(15)17(25)12-20-16(24)9-13-5-2-1-3-6-13/h2,5-6,15H,1,3-4,7-12H2,(H,20,24)(H,21,26)/t15-/m0/s1 |
| InChIKey | ZYVGBKGRQTVDOL-HNNXBMFYSA-N |
| XLogP | 0.41 |
| TPSA | 95.58 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 365.41 |
| LogP ≤ 5 | 0.41 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155418284 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.